Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
about
Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cellsMetuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer.
P2860
Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Biological evaluation of antib ...... of non-small cell lung cancer
@en
type
label
Biological evaluation of antib ...... of non-small cell lung cancer
@en
prefLabel
Biological evaluation of antib ...... of non-small cell lung cancer
@en
P2093
P2860
P1476
Biological evaluation of antib ...... of non-small cell lung cancer
@en
P2093
Hang-Ping Yao
Jianwei Zhou
Liang Feng
Ming-Hai Wang
Ruiwen Zhang
Yong-Qing Zhou
P2860
P2888
P356
10.1186/S13046-016-0347-6
P577
2016-04-22T00:00:00Z
P6179
1022553736